Clinical Pharmacokinetics of Semaglutide: A Systematic Review
Drug Design, Development and Therapy · 2024-06 · Volume 18 · 2555-2570
DOI: 10.2147/dddt.s470826 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Drug Design, Development and Therapy, 2024-06. Verfasst von Xi-Ding Yang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China. Hauptthemen laut MEDLINE: Glucagon-Like Peptides. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.
- Phase I Clinical Trial Center, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.
- Hunan Provincial Engineering Research Central of Translational Medical and Innovative Drug, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.
ORCID-Profile: Yong-Yu Yang
Zitieren
APA
Yang, X. D., & Yang, Y. Y. (2024). Clinical Pharmacokinetics of Semaglutide: A Systematic Review. Drug Design, Development and Therapy, Volume 18, 2555-2570. https://doi.org/10.2147/dddt.s470826
Vancouver
Yang XD, Yang YY. Clinical Pharmacokinetics of Semaglutide: A Systematic Review. Drug Design, Development and Therapy. 2024;Volume 18:2555-2570. doi:10.2147/dddt.s470826
BibTeX
@article{Yang2024,
author = {Yang, Xi-Ding and Yang, Yong-Yu},
title = {Clinical Pharmacokinetics of Semaglutide: A Systematic Review},
journal = {Drug Design, Development and Therapy},
year = {2024},
volume = {Volume 18},
pages = {2555--2570},
doi = {10.2147/dddt.s470826}
}
EUVIMED